Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04178681
Other study ID # NL69492.081.19
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2, 2019
Est. completion date February 28, 2020

Study information

Verified date November 2019
Source Wageningen University
Contact Charlotte Michielsen, MSc
Phone +31 317 484 864
Email charlotte.michielsen@wur.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nowadays, mostly vegetable fat blends are used in infant formula, but the use of bovine milk fat is increasing. In terms of fat structure, bovine milk fat and vegetable fats differ. Bovine milk fat has a higher percentage of palmitic acid attached to the sn-2 position of the glycerol backbone compared to vegetable fat blend. Also bovine milk fat contains milk fat globular membranes, as opposed to vegetable fat. With this study the investigators want to examine the effects of a vegetable fat blend versus bovine milk fat without globular membranes and bovine milk fat with globular membranes on underlying mechanistic, immune and metabolic responses.


Description:

Rationale: Human milk is considered as the ideal food for full-term infants. The composition and function of human milk is unique and has provided the basis for the development of modern artificial milk formulas that mimic its complex biological positive effects on infants and can provide an appropriate substitute for non-breastfed infants. An important component in human milk are the lipids, as they deliver 50% of the total energy to infants. Nowadays, mostly vegetable fat blends are used in infant formula, but the use of bovine milk fat is increasing. In terms of fat structure, bovine milk fat and vegetable fats differ. Bovine milk fat has a higher percentage of palmitic acid attached to the sn-2 position of the glycerol backbone compared to vegetable fat blend. Also bovine milk fat contains milk fat globular membranes, as opposed to vegetable fat. Knowledge on how these differences influence underlying mechanistic, immune and metabolic responses is lacking.

Objectives: The primary objective of this study is to determine the effect of three different fat blends on underlying mechanistic and immune responses in the circulation. The secondary objectives of this study are: 1) to examine the effects of the three different fat blends on postprandial triglyceride concentration and other cardio-metabolic markers in the circulation, 2) to investigate the effect of the three different fat blends on postprandial feelings of hunger and satiety, and 3) to investigate how comparable cytokine measurements are in blood samples obtained via a catheter cannula compared to cytokine measurements in dried blood spots obtained via a finger prick.

Study design: The POEMI Study is a double‐blind randomized cross‐over acute intervention study in which each research subject will visit the university on three separate occasions with a wash-out period of at least one week. At each visit the research subject will undergo one of the three dietary lipid challenge tests (a shake) in a randomized order. On each study day research subjects will be asked to clock in 30 minutes prior to the first data collection points and a catheter cannula will be inserted in a antecubital vein. After the 30 minute rest, blood will be drawn from the catheter cannula and via a finger prick (baseline measurements, t0). After the baseline measurements, the research subjects will have to consume the shake within a time frame of 10 minutes. Blood is again drawn from the catheter cannula at t= 1, 2, 3, 4, 5, 6, 7, and 8 hours after consumption, with an additional finger prick at t=6. A questionnaire on hunger and satiety feelings will be taken after every blood draw.

Study population: The base population will consist of 40 healthy men and women with a BMI ranging from 22 to 27 kg/m2, aged 40 to 70 years old, selected from the surroundings of Wageningen through the mailing list for potential study research subjects of the division of Human Nutrition and health of Wageningen University. If needed, additional recruitment of research subjects will take place by flyers and posters, or advertisements in local newspapers.

Intervention: The dietary lipid challenge tests will be provided in the form of a liquid shake (0.6 L). Each shake will contain 95 gram of fat. The three types of fat that will be tested include: a) 100% vegetable fat blend, b) 100% Anhydrous milk fat (AMF), c) 100% cream (AMF + milk fat globular membranes).


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date February 28, 2020
Est. primary completion date February 28, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Apparently healthy man or woman

- Age 40-70y at the time of recruitment

- BMI of 22-27 kg/m2

- Having a Hb value above 8.4 (men) or 7.4 (women) mmol/L (will be checked at the screening visit)

- Having veins suitable for blood sampling via a catheter cannula (judged by study nurse/ medical doctor)

- Having a general practitioner

- Signed informed consent

Exclusion Criteria:

- Any chronic metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease)

- History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints

- Renal or hepatic malfunctioning (pre-diagnosis or determined based on ALAT, ASAT and creatinine values)

- Use of medication that may influence the study results, such as laxatives, stomach protectors and drugs that can affect intestinal motility.

- Donated or intend to donate blood from 2 months before the study until the end of the study

- Reported slimming, medically prescribed or vegan diet

- Unstable body weight (weight gain or loss >5 kg in the past three months)

- Current smokers

- Alcohol on average: more than 2 consumptions/day or more than 14 consumptions/week

- Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported)

- Use of illicit drugs

- Food allergies for products that the investigators use in the study

- Participation in another clinical trial at the same time, or in the month preceding the start of this study

- Inability to understand study information and/or communicate with staff

- Members of the research team

- Working, or doing an internship or thesis at the division "Human Nutrition and Health", Wageningen University

Study Design


Related Conditions & MeSH terms


Intervention

Other:
100% vegetable blend
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of vegetable fat blend.
100% AMF
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat.
100% cream
Dietary lipid challenge test: 600 ml skimmed milk plus 95 gram of anhydrous milk fat plus milk fat globular membranes.

Locations

Country Name City State
Netherlands Wageningen University, Division of Human Nutrition Wageningen Gelderland

Sponsors (2)

Lead Sponsor Collaborator
Wageningen University Friesland Campina

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Immune cell populations Relative immune cell populations will be determined in whole blood via FACS analysis. Baseline and 6 hours after consumption of the dietary lipid challenge.
Other CRP The CRP value of each research subject will be determined by using a QuikRead CRP test. Before the start of a study day.
Other WHR Both waist and Hip circumference will be measured using a measuring tape. Baseline
Other BMI weight (in kg) and height (in meters) will be measured and combined to report BMI in kg/m^2 Baseline
Other Habitual intake As assessed by a validated FFQ. Baseline
Other Renal or hepatic malfunctioning ALAT (IU/L), ASAT (IU/L) will be measured in a clinical chemical lab. Baseline
Other Renal malfunctioning creatinine (mg/dL) will be measured in a clinical chemical lab. Baseline
Other Anemia Hemoglobin will be determined via a finger prick. Baseline
Primary Change in transcriptomics from baseline to 6 hours after consumption of the three different fat blends, to elucidate underlying mechanistic responses in the circulation. By using untargeted whole genome Affymetrix microarray the investigators will measure gene expression in isolated monocytes. Baseline and 6 hours after consumption of the dietary lipid challenge.
Primary Change in cytokine concentration from baseline and every hour until 8 hours after consumption of the different fat blends, to elucidate the effect on immune responses in the circulation. Cytokine concentrations in the circulation will be measured via ELISA. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Primary Change in functional responses to LPS stimulation of isolated monocytes from the circulation from baseline to 6 hours after consumption of the different fat blends. Cell study with isolated monocytes from the circulation. The cells will be treated with LPS to evaluate functional responses. We will measure fold changes. Baseline and 6 hours after consumption of the dietary lipid challenge.
Primary Change in sensitivity of isolated monocytes from the circulation. Cell study with isolated monocytes from the circulation. The cells will be treated with different fat loads and inflammatory stimuli to evaluate the sensitivity of the collected monocytes. We will measure fold changes. Baseline and 6 hours after consumption of the dietary lipid challenge.
Secondary Postprandial triacylglycerol changes TAG concentration in plasma will be measured in a clinical chemical lab. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial glucose changes Cardio-metabolic markers such as glucose (mg/dl) will be measured in the circulation. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial adiponectin changes Cardio-metabolic markers such as adiponectin (pg/ml) will be measured in the circulation. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial insulin changes Cardio-metabolic markers such as insulin (mIU/L) will be measured in the circulation. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial (untargeted) protein profile changes Using untargeted proteomic platforms, the changes in protein profiles in the circulation will be measured. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial (targeted) protein profile changes Using targeted proteomic platforms, the changes in protein profiles in the circulation will be measured. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial (untargeted) metabolite profile changes Using untargeted metabolomic platforms, the changes in protein profiles in the circulation will be measured. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial (targeted) metabolite profile changes Using targeted metabolomic platforms, the changes in protein profiles in the circulation will be measured. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Postprandial changes in feelings of hunger and satiety Feelings of hunger and satiety will be measured via a questionnaire using a Visual Analog Scale (VAS), a 100 mm line anchored at each end by descriptors. Research subjects will place a mark on the scale that corresponds to their feelings of hunger and satiety. The distance from the lower end of the scale is then measured and recorded. Baseline and every hour until 8 hours after consumption of the dietary lipid challenge.
Secondary Cytokine concentration comparison Cytokine concentrations in the circulation obtained via catheter cannula will be measured via ELISA. The investigators will also measure cytokine concentrations in dried blood spots obtained via a finger prick (via a Meso Scale Discovery Electrochemiluminescence platform). Baseline and 6 hours after consumption of the dietary lipid challenge.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Recruiting NCT05867433 - Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments N/A
Completed NCT02376530 - Price Changes and Nutrient Profiling Among Adult Grocery Shoppers N/A
Completed NCT00957814 - Nutritional Orientations and Adherence, Nutritional Status, Clinical and Life Quality Parameters of Heart Failure (HF) Patients N/A
Completed NCT01040975 - Teen CHAT: Improving Physician Communication With Adolescents About Healthy Weight N/A
Completed NCT00808756 - Study on Fermentable Carbohydrates in Healthy Infants N/A
Completed NCT03290118 - The Efficacy of Front-of-package Labelling Schemes: an Experimental Study N/A
Completed NCT03575884 - Fit 5 Kids Screen Time Reduction Curriculum for Latino Preschoolers N/A
Completed NCT03963778 - Organisational Culture and Nutritional Care
Completed NCT05633251 - Using Reinforcement Schedules to Increase Fruit&Vegetable Intake, Reduce Waste, and Increase School Lunch Participation N/A
Recruiting NCT05977959 - Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors N/A
Recruiting NCT05138276 - Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates Early Phase 1
Completed NCT03906851 - Active and Healthy Kids in Telemark - a School Based Health Promoting Intervention N/A
Not yet recruiting NCT02950779 - Assessment of Handgrip Strength in Adults With Inflammatory Bowel Disease N/A
Completed NCT02486588 - Increasing Engagement With a Healthy Food Benefit N/A
Withdrawn NCT01184027 - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment N/A
Completed NCT01178398 - Understanding Fish Consumption Habits During Pregnancy N/A
Completed NCT01249508 - Nutrition Labeling Program to Promote Healthy Dietary Patterns N/A
Terminated NCT00577499 - Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis N/A
Completed NCT00109551 - Community Trial of Zinc Supplementation on Preschool Child Mortality and Morbidity in Southern Nepal Phase 3